Serum immunoreactive parathyroid hormone (PTH) is increased in obese as compared with nonobese subjects and declines with weight loss. To determine whether alteration of the vitamin D-endocrine system occurs in obesity and whether ensuing secondary hyperparathyroidism is associated with a reduction in urinary calcium, a study was performed in 12 obese white individuals, five men and seven women, and 14 nonobese white subjects, eight men and six women, ranging in age from 20 to 35 yr. Body weight averaged 106 +/-6 kg in the obese and 68 +/-2 kg in the nonobese subjects (P less than 0.01). Each of them were hospitalized on a metabolic ward and were given a constant daily diet containing 400 mg of calcium and 900 mg of phosphorus. Whereas mean serum calcium, serum ionized calcium, and serum phosphorus were the same in the two groups, mean serum immunoreactive PTH (518 +/-48 vs. 243 +/-33 pg/ml, P less than 0.001), mean serum 1,25-dihydroxyvitamin D [1,25(OH)2D] (37 +/-2 vs. 29 +/-2, P less than 0.01), and mean serum Gla protein (33 +/-2 vs. 24 +/-2 ng/ml, P less than 0.02) were significantly higher, and mean serum 25-hydroxyvitamin D (25-OHD) (8 +/-1 vs. 20 +/-2 ng/ml, P less than 0.001) was significantly lower in the obese than in […] Research Article
Abstract
Serum immunoreactive parathyroid hormone (PTH) is increased in obese as compared with nonobese subjects and declines with weight loss. To determine whether alteration of the vitamin Dendocrine system occurs in obesity and whether ensuing secondary hyperparathyroidism is associated with a reduction in urinary calcium, a study was performed in 12 obese white individuals, five men and seven women, and 14 nonobese white subjects, eight men and six women, ranging in age from 20 to 35 yr. Body weight averaged 106±6 kg in the obese and 68±2 kg in the nonobese subjects (P < 0.01). Each of them were hospitalized on a metabolic ward and were given a constant daily diet containing 400 mg of calcium and 900 mg of phosphorus. Whereas mean serum calcium, serum ionized calcium, and serum phosphorus were the same in the two groups, mean serum immunoreactive PTH (518±48 vs. 243±33 pg/ml, P <0.001), mean serum 1,25- (6) after extraction with acetonitrile, washing with phosphate buffer, chromatography on C-18 Sep-Pak, and elution with acetonitrile (7). 25-OHD was separated from other vitamin D metabolites before the binding assay by chromatography on silica Sep-Pak and elution with hexane-propanol (94:6) (7). Serum 1,25(OH)2D was measured by the method of Reinhardt et al. (7) . Serum immunoreactive PTH was measured by radioimmunoassay with a COOH-terminal specific antibody from chicken 77125 at a dilution of 1:10,000 (8) . Serum Gla protein was determined by radioimmunoassay (9) . Urinary cyclic AMP was measured by radioassay with a binding protein (10) . Results are expressed as nM/dl glomerular filtrate (GF) (11) .
Statistical analyses were performed with nonpaired t test and correlation coefficient by standard methods. The percentage of ideal body weight was determined from tables of the Metropolitan Life Insurance Company, New York.
Results
Weights of the obese and nonobese subjects averaged 106±6 tor. Address and 68±2 kg, respectively (P < 0.01). The mean age was 26±1 yr for the obese and 24±1 yr for the nonobese individuals. _______ The results are summarized in Tables I and II and in Fig. 1. Mean serum Gla protein, mean serum immunoreactive PTH, and mean serum 1,25(OH)2D were significantly higher in the obese as compared to the nonobese men and women (Table I) . Mean serum calcium, serum ionized calcium, serum phosphorus, and serum magnesium were the same in the two groups. Mean serum 25-OHD was significantly lower in the obese than in the nonobese individuals. During the 2 d on the constant diet, mean urinary calcium was significantly lower in the obese than in the nonobese subjects (Table II) . Mean urinary cyclic AMP and creatinine clearance were significantly higher in the obese subjects, and mean urinary phosphorus, potassium, and magnesium were the same in the two groups.
As shown in Fig. 1 , in all subjects there was a significant positive correlation between percentage of ideal body weight and urinary cyclic AMP (r = 0.524, P < 0.01). There was also a significant positive correlation between percentage of ideal body weight and serum immunoreactive PTH (r = 0.717, P < 0.01).
Discussion
Bone mass is increased (12) (13) (14) (15) (16) (17) (18) and urinary calcium is diminished (19) (22) . One difference for which we have no explanation is the reduction of serum Gla protein in blacks in our previous study and the increase of serum Gla protein in the obese as compared with nonobese white subjects, which was seen in the present investigation. We interpret our results to indicate that alteration of the vitamin D-endocrine system also occurs in obesity, and is characterized by secondary increases in circulating PTH with consequent enhanced tubular reabsorption in calcium and increased renal production of 1,25(OH)2D.
An alternative explanation for our findings in obese men and women is impaired intestinal absorption of calcium. This possibility appears unlikely, since malabsorption of calcium, if prolonged, would lead to a decline in bone mass. In this As noted already, increased bone mass in blacks is thought to result from an increased muscle mass (13) . If greater strain on the skeleton produced by the increased body weight diminishes the skeletal response to PTH in obesity, the elevated serum immunoreactive PTH should decline with weight loss. Atkinson et al. (1) followed 27 massively obese subjects for periods of up to 1 yr after jejunal-ileal intestinal bypass, and noted that serum immunoreactive PTH decreased with weight loss. Indeed, the reductions in body weight and serum immunoreactive PTH paralleled each other. Thus, at 6 mo after surgery there was a significant correlation between the amount of weight loss, which averaged 44 kg, and the decrease in serum immunoreactive PTH (1) .
Mean serum 25-OHD was lower in the obese than in the nonobese subjects. A reduction in mean serum 25-OHD was also found in two other groups of obese individuals, one of which had undergone jejunal-ileal bypass (24, 25) . In these subjects, there was a progressive increase in serum 25-OHD after surgery to values that were in the normal range. In view of the present findings, and the previously described decline in elevation of serum immunoreactive PTH in association with weight loss after intestinal bypass (1) 
